During the corresponding time, Petvivo Holdings Inc sequentially revenue grew by 32.54 %. While revenue at the Petvivo Holdings Inc 's corporate clients
Petvivo Holdings Inc's Comment on Sales, Marketing and Customers
The Company serves licensed veterinary practices, including customers who have previously purchased Spryng®, those requiring direct transactions, governmental agencies, and customers ordering online without direct solicitation by MWI. It has non-exclusive distribution agreements with MWI, Covetrus North America, LLC, Vedco Inc., and Clipper Distributing, LLC, all of which market, distribute, and supply products to veterinarians. The Company’s products, including Spryng®, are classified as veterinary medical devices and have undergone clinical studies with institutions such as Colorado State University and Ethos Veterinary Health to support distribution expansion. Manufacturing takes place in ISO 7 certified clean room facilities in Minneapolis, with plans for a second facility to increase production capacity and research capabilities. The Company’s pipeline includes 17 therapeutic devices intended for veterinary and human clinical applications.
Petvivo Holdings Inc’s Comment on Sales, Marketing and Customers
The Company serves licensed veterinary practices, including customers who have previously purchased Spryng®, those requiring direct transactions, governmental agencies, and customers ordering online without direct solicitation by MWI. It has non-exclusive distribution agreements with MWI, Covetrus North America, LLC, Vedco Inc., and Clipper Distributing, LLC, all of which market, distribute, and supply products to veterinarians. The Company’s products, including Spryng®, are classified as veterinary medical devices and have undergone clinical studies with institutions such as Colorado State University and Ethos Veterinary Health to support distribution expansion. Manufacturing takes place in ISO 7 certified clean room facilities in Minneapolis, with plans for a second facility to increase production capacity and research capabilities. The Company’s pipeline includes 17 therapeutic devices intended for veterinary and human clinical applications.
Sources:
Petvivo Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Petvivo Holdings Inc’s corporate clients.
For your research, we’ve provided 9 tables on Petvivo Holdings Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
100 %